Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. Sep 15, 2017; 9(9): 379-384
Published online Sep 15, 2017. doi: 10.4251/wjgo.v9.i9.379
Published online Sep 15, 2017. doi: 10.4251/wjgo.v9.i9.379
Figure 1 Tumor response.
CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progressive disease.
Figure 2 Effects of chemoembolization with polyethilene glycol microspheres loaded with irinotecan.
A: Before LIFIRI: Voluminous non resectable metastases in the right lobe; B: One month after LIFIRI: Reduction of contrast enhancement and increase of necrotic areas; C: Three months after LIFIRI: Tumor shrinkage and reduction of viable tissue; D: Six months after LIFIRI: Metastases appears almost completely necrotic and reduced in diameter (as shown by circles around tumor mass).
- Citation: Fiorentini G, Carandina R, Sarti D, Nardella M, Zoras O, Guadagni S, Inchingolo R, Nestola M, Felicioli A, Barnes Navarro D, Munos Gomez F, Aliberti C. Polyethylene glycol microspheres loaded with irinotecan for arterially directed embolic therapy of metastatic liver cancer. World J Gastrointest Oncol 2017; 9(9): 379-384
- URL: https://www.wjgnet.com/1948-5204/full/v9/i9/379.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i9.379